Drug General Information (ID: D1563)
  Drug Name
Tetracosactide
  Drug Type Small molecule
  Drug Synonymous
Tetracosactide; COSYNTROPIN; 16960-16-0; Tetracosactrin; Tetracosactide acetate; VICOTROPE; Cortrosyn; CHEBI:3901; Cosyntropin acetate; CORTICOTROPIN TETRACOSAPEPTIDE; Cosyntropin hexaacetate; Tetracosactide hexaacetate; C136H210N40O31S; Tetracosactide hexacetate; TetracosactrinTetracosactrin; SCHEMBL33366; ACTH (1-24), Human; CHEMBL2103784; AMY25377; BDBM50017180; AKOS015994630; HS-2001; U943; 960S160; W-107889; Adrenocorticotropic Hormone Fragment 1-24 human, rat, >=97% (HPLC); H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH; L-Seryl-L-tyrosyl-L-seryl-L-methionyl-L-glutamyl-L-alpha-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valylglycyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-prolyl-L-valyl-L-lysyl-L-valyl-L-tyrosyl-L-proline
    Click to Show/Hide
  Therapeutic Class Diagnostic Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C136H210N40O31S
  InChI InChI=1S/C136H210N40O31S/c1-75(2)109(127(200)154-71-106(181)156-88(31-13-17-52-137)114(187)158-89(32-14-18-53-138)115(188)159-91(35-21-56-149-134(142)143)116(189)164-96(37-23-58-151-136(146)147)131(204)175-60-25-39-104(175)126(199)173-111(77(5)6)128(201)163-90(33-15-19-54-139)120(193)171-110(76(3)4)129(202)169-101(65-80-43-47-84(180)48-44-80)132(205)176-61-26-40-105(176)133(206)207)172-125(198)103-38-24-59-174(103)130(203)95(34-16-20-55-140)157-107(182)70-153-113(186)99(66-81-68-152-87-30-12-11-29-85(81)87)167-117(190)92(36-22-57-150-135(144)145)160-121(194)98(63-78-27-9-8-10-28-78)166-123(196)100(67-82-69-148-74-155-82)168-118(191)93(49-50-108(183)184)161-119(192)94(51-62-208-7)162-124(197)102(73-178)170-122(195)97(165-112(185)86(141)72-177)64-79-41-45-83(179)46-42-79/h8-12,27-30,41-48,68-69,74-77,86,88-105,109-111,152,177-180H,13-26,31-40,49-67,70-73,137-141H2,1-7H3,(H,148,155)(H,153,186)(H,154,200)(H,156,181)(H,157,182)(H,158,187)(H,159,188)(H,160,194)(H,161,192)(H,162,197)(H,163,201)(H,164,189)(H,165,185)(H,166,196)(H,167,190)(H,168,191)(H,169,202)(H,170,195)(H,171,193)(H,172,198)(H,173,199)(H,183,184)(H,206,207)(H4,142,143,149)(H4,144,145,150)(H4,146,147,151)/t86-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,109-,110-,111-/m0/s1
  InChIKey ZOEFCCMDUURGSE-SQKVDDBVSA-N
  Canonical SMILES CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC8=CNC=N8)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)[C@H](CO)N
  External Link
Pubchem ID 16133802

Drug-Drug Interaction Network
  Sunburst Graph
AM003  Affected organization distribution
AM004  Affected intra/extra-hepatic metabolism
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM014  Interference of cell/tissue uptake
BM015  Increase globulin concentration
BM017  CYP450 enzyme inhibition
BM022  CYP450 enzyme induction
BM043  Additive immunosuppressive effects
BM050  Increased risk of bleeding
BM065  Increased risk of hypokalemia
BM069  Increased risk of lowers seizure threshold
BM081  Increased risk of ventricular arrhythmias
BM083  Potentiated the pharmacological effects (Unspecific)
BM086  Antagonize the effect of antidiabetic agents
BM089  Antagonize the effect of antihypertensive agents
BM091  Antagonize the effect of cholinergic agents
BM092  Antagonize the effect of corticosteroids
BM100  Antagonize the effect of vaccine/toxoid
BM106  Diminish the response to diagnostic skin test antigens
BM107  Attenuated pharmacological effects (Unspecific)
  Relation Graph
 Full list of drugs interacting with Tetracosactide
      Affected organization distribution
   Interference of cell/tissue uptake Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1817
 
Indium In-111 oxyquinoline
 
C27H18InN3O3
 
16685037 
Moderate    Inter Info   
[78]
   Increase globulin concentration Drug Num:  14
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0387
 
Conjugated estrogens
 
C18H21NaO5S
 
45357473 
Moderate    Inter Info   
[53], [54], [55]
D0388
 
Conjugated estrogens (topical)
 
C18H21NaO5S
 
45357473 
Moderate    Inter Info   
[53], [54], [55]
D0484
 
Dienestrol (topical)
 
C18H18O2
 
667476 
Moderate    Inter Info   
[53], [54], [55]
D0487
 
Diethylstilbestrol
 
C18H20O2
 
448537 
Moderate    Inter Info   
[53], [54], [55]
D0606
 
Estradiol
 
C18H24O2
 
5757 
Moderate    Inter Info   
[53], [54], [55]
D0607
 
Estradiol (topical)
 
C18H24O2
 
5757 
Moderate    Inter Info   
[53], [54], [55]
D0608
 
Estramustine
 
C23H31Cl2NO3
 
259331 
Moderate    Inter Info   
[53], [54], [55]
D0609
 
Estrone
 
C18H22O2
 
5870 
Moderate    Inter Info   
[53], [54], [55]
D0619
 
Ethinylestradiol
 
C20H24O2
 
5991 
Moderate    Inter Info   
[53], [54], [55]
D0605
 
Esterified estrogens
 
NA
 
NA
Moderate    Inter Info   
[53], [54], [55]
D0610
 
Estrone sulfate
 
C18H22O5S
 
3001028 
Moderate    Inter Info   
[53], [54], [55]
D0611
 
Estrone sulfate (topical)
 
C18H22O5S
 
3001028 
Moderate    Inter Info   
[53], [54], [55]
D1011
 
Mestranol
 
C21H26O2
 
6291 
Moderate    Inter Info   
[53], [54], [55]
D1370
 
Quinestrol
 
C25H32O2
 
9046 
Moderate    Inter Info   
[53], [54], [55]
      Affected intra/extra-hepatic metabolism
   CYP450 enzyme induction Drug Num:  9
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0224
 
Butabarbital
 
C10H16N2O3
 
2479 
Moderate    Inter Info   
[47], [48], [49]
D0225
 
Butalbital
 
C11H16N2O3
 
2481 
Moderate    Inter Info   
[47], [48], [49]
D0255
 
Carbamazepine
 
C15H12N2O
 
2554 
Moderate    Inter Info   
[50], [51], [52]
D1040
 
Methylphenobarbital
 
C13H14N2O3
 
8271 
Moderate    Inter Info   
[47], [48], [49]
D1248
 
Pentobarbital
 
C11H18N2O3
 
4737 
Moderate    Inter Info   
[47], [48], [49]
D1265
 
Phenobarbital
 
C12H12N2O3
 
4763 
Moderate    Inter Info   
[47], [48], [49]
D1340
 
Primidone
 
C12H14N2O2
 
4909 
Moderate    Inter Info   
[47], [48], [49]
D1453
 
Secobarbital
 
C12H18N2O3
 
5193 
Moderate    Inter Info   
[47], [48], [49]
D0071
 
Amobarbital
 
C11H18N2O3
 
2164 
Moderate    Inter Info   
[47], [48], [49]
      Pharmacodynamic additive effects
   Additive immunosuppressive effects Drug Num:  28
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0023
 
Adalimumab
 
NA
 
NA
Major    Inter Info   
[1], [2], [3]
D0348
 
Cladribine
 
C10H12ClN5O3
 
20279 
Major    Inter Info   
[7], [8]
D0614
 
Etanercept
 
NA
 
NA
Major    Inter Info   
[1], [2], [3]
D0802
 
Infliximab
 
NA
 
NA
Major    Inter Info   
[1], [2], [3]
D0900
 
Leflunomide
 
C12H9F3N2O2
 
3899 
Major    Inter Info   
[9], [10]
D1111
 
Natalizumab
 
NA
 
NA
Major    Inter Info   
[13]
D0146
 
Baricitinib
 
C16H17N7O2S
 
44205240 
Major    Inter Info   
[14], [7], [15]
D0304
 
Certolizumab pegol
 
NA
 
NA
Major    Inter Info   
[1], [2], [3]
D0661
 
Fingolimod
 
C19H33NO2
 
107970 
Major    Inter Info   
[19]
D0736
 
Golimumab
 
NA
 
NA
Major    Inter Info   
[1], [2], [3]
D1211
 
Ozanimod
 
C23H24N4O3
 
52938427 
Major    Inter Info   
[7], [20]
D1474
 
Siponimod
 
C29H35F3N2O3
 
44599207 
Major    Inter Info   
[14], [21]
D1556
 
Teriflunomide
 
C12H9F3N2O2
 
54684141 
Major    Inter Info   
[9], [10]
D1600
 
Tofacitinib
 
C16H20N6O
 
9926791 
Major    Inter Info   
[25]
D1666
 
Upadacitinib
 
C17H19F3N6O
 
58557659 
Major    Inter Info   
[26]
D0032
 
Alefacept
 
NA
 
NA
Moderate    Inter Info   
[22], [35], [36]
D0033
 
Alemtuzumab
 
NA
 
NA
Moderate    Inter Info   
[37], [36]
D0085
 
Anakinra
 
C20H23N5O7S2
 
146171046 
Moderate    Inter Info   
[44], [45], [46]
D0553
 
Efalizumab
 
NA
 
NA
Moderate    Inter Info   
[56]
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Moderate    Inter Info   
[63], [64], [65]
D0246
 
Canakinumab
 
NA
 
NA
Moderate    Inter Info   
[44], [45], [46]
D0443
 
Denosumab
 
NA
 
NA
Moderate    Inter Info   
[36], [76]
D0499
 
Dimethyl fumarate
 
C6H8O4
 
637568 
Moderate    Inter Info   
[77]
D1085
 
Monomethyl fumarate
 
C5H6O4
 
5369209 
Moderate    Inter Info   
[77]
D1162
 
Ocrelizumab
 
NA
 
NA
Moderate    Inter Info   
[79]
D1403
 
Rilonacept
 
NA
 
NA
Moderate    Inter Info   
[44], [45], [46]
D1422
 
Roflumilast
 
C17H14Cl2F2N2O3
 
449193 
Moderate    Inter Info   
[7], [80]
D1671
 
Ustekinumab
 
NA
 
NA
Moderate    Inter Info   
[81]
   Increased risk of bleeding Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0447
 
Desirudin
 
C287H440N80O110S6
 
16129703 
Major    Inter Info   
[16], [17], [18]
   Increased risk of hypokalemia Drug Num:  52
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0012
 
Acetazolamide
 
C4H6N4O3S2
 
1986 
Moderate    Inter Info   
[31], [32], [33]
D0064
 
Aminophylline
 
C16H24N10O4
 
9433 
Moderate    Inter Info   
[41], [42], [43]
D0075
 
Amphotericin B
 
C47H73NO17
 
5280965 
Moderate    Inter Info   
[31], [32], [33]
D0076
 
Amphotericin B (cholesteryl sulfate)
 
C47H73NO17
 
5280965 
Moderate    Inter Info   
[31], [32], [33]
D0077
 
Amphotericin B (lipid complex)
 
C47H73NO17
 
5280965 
Moderate    Inter Info   
[31], [32], [33]
D0078
 
Amphotericin B (liposomal)
 
C47H73NO17
 
5280965 
Moderate    Inter Info   
[31], [32], [33]
D0158
 
Bendroflumethiazide
 
C15H14F3N3O4S2
 
2315 
Moderate    Inter Info   
[31], [32], [33]
D0166
 
Benzthiazide
 
C15H14ClN3O4S3
 
2343 
Moderate    Inter Info   
[31], [32], [33]
D0217
 
Bumetanide
 
C17H20N2O5S
 
2471 
Moderate    Inter Info   
[31], [32], [33]
D0252
 
Capreomycin
 
C50H88N28O15
 
3000502 
Moderate    Inter Info   
[31], [32], [33]
D0321
 
Chlorothiazide
 
C7H6ClN3O4S2
 
2720 
Moderate    Inter Info   
[31], [32], [33]
D0326
 
Chlorthalidone
 
C14H11ClN2O4S
 
2732 
Moderate    Inter Info   
[31], [32], [33]
D0344
 
Cisplatin
 
Cl2H6N2Pt
 
5702198 
Moderate    Inter Info   
[31], [32], [33]
D0479
 
Diclofenamide
 
C6H6Cl2N2O4S2
 
3038 
Moderate    Inter Info   
[31], [32], [33]
D0613
 
Etacrynic acid
 
C13H12Cl2O4
 
3278 
Moderate    Inter Info   
[31], [32], [33]
D0694
 
Foscarnet
 
CH3O5P
 
3415 
Moderate    Inter Info   
[31], [32], [33]
D0704
 
Furosemide
 
C12H11ClN2O5S
 
3440 
Moderate    Inter Info   
[31], [32], [33]
D0771
 
Hydrochlorothiazide
 
C7H8ClN3O4S2
 
3639 
Moderate    Inter Info   
[31], [32], [33]
D0798
 
Indapamide
 
C16H16ClN3O3S
 
3702 
Moderate    Inter Info   
[31], [32], [33]
D0888
 
Lactulose
 
C12H22O11
 
11333 
Moderate    Inter Info   
[59], [60], [61]
D0975
 
Magnesium sulfate
 
MgO4S
 
24083 
Moderate    Inter Info   
[59], [60], [61]
D1048
 
Metolazone
 
C16H16ClN3O3S
 
4170 
Moderate    Inter Info   
[31], [32], [33]
D0184
 
Bisacodyl
 
C22H19NO4
 
2391 
Moderate    Inter Info   
[59], [60], [61]
D0269
 
Castor oil
 
C57H104O9
 
14030006 
Moderate    Inter Info   
[59], [60], [61]
D0701
 
Frangula purshiana bark
 
NA
 
NA
Moderate    Inter Info   
[59], [60], [61]
D0731
 
Glycerin
 
C3H8O3
 
753 
Moderate    Inter Info   
[59], [60], [61]
D0887
 
Lactitol
 
C12H24O11
 
157355 
Moderate    Inter Info   
[59], [60], [61]
D0970
 
Magnesium citrate
 
C12H10Mg3O14
 
6099959 
Moderate    Inter Info   
[59], [60], [61]
D0973
 
Magnesium hydroxide
 
H2MgO2
 
14791 
Moderate    Inter Info   
[59], [60], [61]
D1069
 
Mineral oil
 
NA
 
NA
Moderate    Inter Info   
[59], [60], [61]
D1231
 
Patiromer
 
NA
 
NA
Moderate    Inter Info   
[31], [32], [33]
D1266
 
Phenolphthalein
 
C20H14O4
 
4764 
Moderate    Inter Info   
[59], [60], [61]
D1287
 
Picosulfuric acid
 
C18H15NO8S2
 
5243 
Moderate    Inter Info   
[59], [60], [61]
D1311
 
Polythiazide
 
C11H13ClF3N3O4S3
 
4870 
Moderate    Inter Info   
[31], [32], [33]
D1605
 
Tolevamer
 
C11H16O3S
 
58817179 
Moderate    Inter Info   
[31], [32], [33]
D1570
 
Theophylline
 
C7H8N4O2
 
2153 
Moderate    Inter Info   
[41], [42], [43]
D1611
 
Torasemide
 
C16H20N4O3S
 
41781 
Moderate    Inter Info   
[31], [32], [33]
D1633
 
Trichlormethiazide
 
C8H8Cl3N3O4S2
 
5560 
Moderate    Inter Info   
[31], [32], [33]
D0103
 
Arformoterol
 
C19H24N2O4
 
3083544 
Minor    Inter Info   
[14], [7], [82]
D0691
 
Formoterol
 
C19H24N2O4
 
3410 
Minor    Inter Info   
[14], [7], [82]
D0854
 
Isoetharine
 
C13H21NO3
 
3762 
Minor    Inter Info   
[14], [7], [82]
D0859
 
Isoprenaline
 
C11H17NO3
 
3779 
Minor    Inter Info   
[14], [7], [82]
D1185
 
Orciprenaline
 
C11H17NO3
 
4086 
Minor    Inter Info   
[14], [7], [82]
D1414
 
Ritodrine
 
C17H21NO3
 
33572 
Minor    Inter Info   
[14], [7], [82]
D1438
 
Salbutamol
 
C13H21NO3
 
2083 
Minor    Inter Info   
[14], [7], [82]
D1440
 
Salmeterol
 
C25H37NO4
 
5152 
Minor    Inter Info   
[14], [7], [82]
D1554
 
Terbutaline
 
C12H19NO3
 
5403 
Minor    Inter Info   
[14], [7], [82]
D0797
 
Indacaterol
 
C24H28N2O3
 
6918554 
Minor    Inter Info   
[14], [7], [82]
D0924
 
Levosalbutamol
 
C13H21NO3
 
123600 
Minor    Inter Info   
[14], [7], [82]
D1298
 
Pirbuterol
 
C12H20N2O3
 
4845 
Minor    Inter Info   
[14], [7], [82]
D1374
 
Racepinephrine
 
C9H13NO3
 
838 
Minor    Inter Info   
[14], [7], [82]
D1695
 
Vilanterol
 
C24H33Cl2NO5
 
10184665 
Minor    Inter Info   
[14], [7], [82]
   Increased risk of lowers seizure threshold Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0220
 
Bupropion
 
C13H18ClNO
 
444 
Major    Inter Info   
[4], [5], [6]
D0054
 
Amifampridine
 
C5H7N3
 
5918 
Moderate    Inter Info   
[66], [67]
   Increased risk of ventricular arrhythmias Drug Num:  9
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0324
 
Chlorpromazine
 
C17H19ClN2S
 
2726 
Moderate    Inter Info   
[14], [7]
D0678
 
Fluphenazine
 
C22H26F3N3OS
 
3372 
Moderate    Inter Info   
[14], [7]
D0750
 
Haloperidol
 
C21H23ClFNO2
 
3559 
Moderate    Inter Info   
[14], [7]
D1215
 
Paliperidone
 
C23H27FN4O3
 
115237 
Moderate    Inter Info   
[14], [7]
D1351
 
Promazine
 
C17H20N2S
 
4926 
Moderate    Inter Info   
[14], [7]
D1413
 
Risperidone
 
C23H27FN4O2
 
5073 
Moderate    Inter Info   
[14], [7]
D0067
 
Amisulpride
 
C17H27N3O4S
 
2159 
Moderate    Inter Info   
[14], [7]
D1574
 
Thioridazine
 
C21H26N2S2
 
5452 
Moderate    Inter Info   
[14], [7]
D1637
 
Trifluoperazine
 
C21H24F3N3S
 
5566 
Moderate    Inter Info   
[14], [7]
   Potentiated the pharmacological effects (Unspecific) Drug Num:  7
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0677
 
Fluoxymesterone
 
C20H29FO3
 
6446 
Moderate    Inter Info   
[57], [58]
D1195
 
Oxandrolone
 
C19H30O3
 
5878 
Moderate    Inter Info   
[57], [58]
D1558
 
Testosterone
 
C19H28O2
 
6013 
Moderate    Inter Info   
[57], [58]
D1559
 
Testosterone (topical)
 
C19H28O2
 
6013 
Moderate    Inter Info   
[57], [58]
D1042
 
Methyltestosterone
 
C20H30O2
 
6010 
Moderate    Inter Info   
[57], [58]
D1207
 
Oxymetholone
 
C21H32O3
 
5281034 
Moderate    Inter Info   
[57], [58]
D1503
 
Stanozolol
 
C21H32N2O
 
25249 
Moderate    Inter Info   
[57], [58]
      Pharmacodynamic antagonistic effects
   Antagonize the effect of antidiabetic agents Drug Num:  38
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0009
 
Acarbose
 
C25H43NO18
 
41774 
Moderate    Inter Info   
[27], [28], [29]
D0013
 
Acetohexamide
 
C15H20N2O4S
 
1989 
Moderate    Inter Info   
[27], [28], [29]
D0325
 
Chlorpropamide
 
C10H13ClN2O3S
 
2727 
Moderate    Inter Info   
[27], [28], [29]
D1784
 
Exenatide
 
C184H282N50O60S
 
45588096 
Moderate    Inter Info   
[27], [28], [29]
D0727
 
Glimepiride
 
C24H34N4O5S
 
3476 
Moderate    Inter Info   
[27], [28], [29]
D0728
 
Glipizide
 
C21H27N5O4S
 
3478 
Moderate    Inter Info   
[27], [28], [29]
D0730
 
Glyburide
 
C23H28ClN3O5S
 
3488 
Moderate    Inter Info   
[27], [28], [29]
D0811
 
Insulin glargine
 
C267H404N72O78S6
 
118984454 
Moderate    Inter Info   
[27], [28], [29]
D0813
 
Insulin human
 
C257H383N65O77S6
 
118984375 
Moderate    Inter Info   
[27], [28], [29]
D0814
 
Insulin human (inhalation, rapid acting)
 
C257H383N65O77S6
 
118984375 
Moderate    Inter Info   
[27], [28], [29]
D0815
 
Insulin human (isophane)
 
C257H383N65O77S6
 
118984375 
Moderate    Inter Info   
[27], [28], [29]
D0816
 
Insulin human (regular)
 
C257H383N65O77S6
 
118984375 
Moderate    Inter Info   
[27], [28], [29]
D0817
 
Insulin human (zinc extended)
 
C257H383N65O77S6
 
118984375 
Moderate    Inter Info   
[27], [28], [29]
D0819
 
Insulin lispro
 
C257H389N65O77S6
 
16132438 
Moderate    Inter Info   
[27], [28], [29]
D0820
 
Insulin lispro (protamine)
 
C257H389N65O77S6
 
16132438 
Moderate    Inter Info   
[27], [28], [29]
D1015
 
Metformin
 
C4H11N5
 
4091 
Moderate    Inter Info   
[27], [28], [29]
D1064
 
Miglitol
 
C8H17NO5
 
441314 
Moderate    Inter Info   
[27], [28], [29]
D1112
 
Nateglinide
 
C19H27NO3
 
5311309 
Moderate    Inter Info   
[27], [28], [29]
D1294
 
Pioglitazone
 
C19H20N2O3S
 
4829 
Moderate    Inter Info   
[27], [28], [29]
D1326
 
Pramlintide
 
C171H267N51O53S2
 
70691388 
Moderate    Inter Info   
[27], [28], [29]
D1392
 
Repaglinide
 
C27H36N2O4
 
65981 
Moderate    Inter Info   
[27], [28], [29]
D1429
 
Rosiglitazone
 
C18H19N3O3S
 
77999 
Moderate    Inter Info   
[27], [28], [29]
D1477
 
Sitagliptin
 
C16H15F6N5O
 
4369359 
Moderate    Inter Info   
[27], [28], [29]
D0029
 
Albiglutide
 
C148H224N40O45
 
145994868 
Moderate    Inter Info   
[27], [28], [29]
D0042
 
Alogliptin
 
C18H21N5O2
 
11450633 
Moderate    Inter Info   
[27], [28], [29]
D0245
 
Canagliflozin
 
C24H25FO5S
 
24812758 
Moderate    Inter Info   
[27], [28], [29]
D0418
 
Dapagliflozin
 
C21H25ClO6
 
9887712 
Moderate    Inter Info   
[27], [28], [29]
D0565
 
Empagliflozin
 
C23H27ClO7
 
11949646 
Moderate    Inter Info   
[27], [28], [29]
D0807
 
Insulin aspart (aspart protamine)
 
C256H381N65O79S6
 
118984445 
Moderate    Inter Info   
[27], [28], [29]
D0808
 
Insulin aspart (aspart)
 
C256H381N65O79S6
 
118984445 
Moderate    Inter Info   
[27], [28], [29]
D0809
 
Insulin degludec
 
C274H411N65O81S6
 
118984462 
Moderate    Inter Info   
[27], [28], [29]
D0810
 
Insulin detemir
 
C267H402N64O76S6
 
16137271 
Moderate    Inter Info   
[27], [28], [29]
D0930
 
Linagliptin
 
C25H28N8O2
 
10096344 
Moderate    Inter Info   
[27], [28], [29]
D0936
 
Liraglutide
 
C172H265N43O51
 
16134956 
Moderate    Inter Info   
[27], [28], [29]
D1449
 
Saxagliptin
 
C18H25N3O2
 
11243969 
Moderate    Inter Info   
[27], [28], [29]
D1601
 
Tolazamide
 
C14H21N3O3S
 
5503 
Moderate    Inter Info   
[27], [28], [29]
D1603
 
Tolbutamide
 
C12H18N2O3S
 
5505 
Moderate    Inter Info   
[27], [28], [29]
D1652
 
Troglitazone
 
C24H27NO5S
 
5591 
Moderate    Inter Info   
[27], [28], [29]
   Antagonize the effect of antihypertensive agents Drug Num:  63
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0010
 
Acebutolol
 
C18H28N2O4
 
1978 
Moderate    Inter Info   
[7], [30]
D0058
 
Amiloride
 
C6H8ClN7O
 
16231 
Moderate    Inter Info   
[7], [30]
D0069
 
Amlodipine
 
C20H25ClN2O5
 
2162 
Moderate    Inter Info   
[7], [30]
D0117
 
Atenolol
 
C14H22N2O3
 
2249 
Moderate    Inter Info   
[7], [30]
D0156
 
Benazepril
 
C24H28N2O5
 
5362124 
Moderate    Inter Info   
[7], [30]
D0173
 
Betaxolol
 
C18H29NO3
 
2369 
Moderate    Inter Info   
[7], [30]
D0188
 
Bisoprolol
 
C18H31NO4
 
2405 
Moderate    Inter Info   
[7], [30]
D0254
 
Captopril
 
C9H15NO3S
 
44093 
Moderate    Inter Info   
[7], [30]
D0265
 
Carteolol
 
C16H24N2O3
 
2583 
Moderate    Inter Info   
[7], [30]
D0267
 
Carvedilol
 
C24H26N2O4
 
2585 
Moderate    Inter Info   
[7], [30]
D0363
 
Clonidine
 
C9H9Cl2N3
 
2803 
Moderate    Inter Info   
[7], [30]
D0444
 
Deserpidine
 
C32H38N2O8
 
8550 
Moderate    Inter Info   
[7], [30]
D0474
 
Diazoxide
 
C8H7ClN2O2S
 
3019 
Moderate    Inter Info   
[7], [30]
D0497
 
Diltiazem
 
C22H26N2O4S
 
39186 
Moderate    Inter Info   
[7], [30]
D0524
 
Doxazosin
 
C23H25N5O5
 
3157 
Moderate    Inter Info   
[7], [30]
D0567
 
Enalapril
 
C20H28N2O5
 
5388962 
Moderate    Inter Info   
[7], [30]
D0585
 
Eplerenone
 
C24H30O6
 
443872 
Moderate    Inter Info   
[7], [30]
D0587
 
Eprosartan
 
C23H24N2O4S
 
5281037 
Moderate    Inter Info   
[7], [30]
D0640
 
Felodipine
 
C18H19Cl2NO4
 
3333 
Moderate    Inter Info   
[7], [30]
D0644
 
Fenoldopam
 
C16H16ClNO3
 
3341 
Moderate    Inter Info   
[7], [30]
D0695
 
Fosinopril
 
C30H46NO7P
 
55891 
Moderate    Inter Info   
[7], [30]
D0742
 
Guanabenz
 
C8H8Cl2N4
 
5702063 
Moderate    Inter Info   
[7], [30]
D0743
 
Guanadrel
 
C10H19N3O2
 
38521 
Moderate    Inter Info   
[7], [30]
D0744
 
Guanethidine
 
C10H22N4
 
3518 
Moderate    Inter Info   
[7], [30]
D0745
 
Guanfacine
 
C9H9Cl2N3O
 
3519 
Moderate    Inter Info   
[7], [30]
D0770
 
Hydralazine
 
C8H8N4
 
3637 
Moderate    Inter Info   
[7], [30]
D0844
 
Irbesartan
 
C25H28N6O
 
3749 
Moderate    Inter Info   
[7], [30]
D0865
 
Isradipine
 
C19H21N3O5
 
3784 
Moderate    Inter Info   
[7], [30]
D0884
 
Labetalol
 
C19H24N2O3
 
3869 
Moderate    Inter Info   
[7], [30]
D0938
 
Lisinopril
 
C21H31N3O5
 
5362119 
Moderate    Inter Info   
[7], [30]
D0954
 
Losartan
 
C22H23ClN6O
 
3961 
Moderate    Inter Info   
[7], [30]
D1035
 
Methyldopa
 
C10H13NO4
 
38853 
Moderate    Inter Info   
[7], [30]
D1049
 
Metoprolol
 
C15H25NO3
 
4171 
Moderate    Inter Info   
[7], [30]
D1072
 
Minoxidil
 
C9H15N5O
 
4201 
Moderate    Inter Info   
[7], [30]
D1082
 
Moexipril
 
C27H34N2O7
 
91270 
Moderate    Inter Info   
[7], [30]
D1098
 
Nadolol
 
C17H27NO4
 
39147 
Moderate    Inter Info   
[7], [30]
D1130
 
Nicardipine
 
C26H29N3O6
 
4474 
Moderate    Inter Info   
[7], [30]
D1134
 
Nifedipine
 
C17H18N2O6
 
4485 
Moderate    Inter Info   
[7], [30]
D1147
 
Nitroprusside
 
C5FeN6O
 
11953891 
Moderate    Inter Info   
[7], [30]
D1170
 
Olmesartan
 
C24H26N6O3
 
158781 
Moderate    Inter Info   
[7], [30]
D1256
 
Perindopril
 
C19H32N2O5
 
107807 
Moderate    Inter Info   
[7], [30]
D1331
 
Prazosin
 
C19H21N5O4
 
4893 
Moderate    Inter Info   
[7], [30]
D1357
 
Propranolol
 
C16H21NO2
 
4946 
Moderate    Inter Info   
[7], [30]
D1369
 
Quinapril
 
C25H30N2O5
 
54892 
Moderate    Inter Info   
[7], [30]
D1379
 
Ramipril
 
C23H32N2O5
 
5362129 
Moderate    Inter Info   
[7], [30]
D1393
 
Reserpine
 
C33H40N2O9
 
5770 
Moderate    Inter Info   
[7], [30]
D1501
 
Spironolactone
 
C24H32O4S
 
5833 
Moderate    Inter Info   
[7], [30]
D1552
 
Terazosin
 
C19H25N5O4
 
5401 
Moderate    Inter Info   
[7], [30]
D0038
 
Aliskiren
 
C30H53N3O6
 
5493444 
Moderate    Inter Info   
[7], [30]
D0138
 
Azilsartan medoxomil
 
C30H24N4O8
 
135409642 
Moderate    Inter Info   
[7], [30]
D0352
 
Clevidipine
 
C21H23Cl2NO6
 
153994 
Moderate    Inter Info   
[7], [30]
D1779
 
Dulaglutide
 
NA
 
NA
Moderate    Inter Info   
[27], [28], [29]
D1782
 
Ertugliflozin
 
C22H25ClO7
 
44814423 
Moderate    Inter Info   
[27], [28], [29]
D0911
 
Levamlodipine
 
C20H25ClN2O5
 
9822750 
Moderate    Inter Info   
[7], [30]
D1114
 
Nebivolol
 
C22H25F2NO4
 
71301 
Moderate    Inter Info   
[7], [30]
D1244
 
Penbutolol
 
C18H29NO2
 
37464 
Moderate    Inter Info   
[7], [30]
D1887
 
Semaglutide
 
C187H291N45O59
 
56843331 
Moderate    Inter Info   
[27], [28], [29]
D1585
 
Timolol
 
C13H24N4O3S
 
33624 
Moderate    Inter Info   
[7], [30]
D1618
 
Trandolapril
 
C24H34N2O5
 
5484727 
Moderate    Inter Info   
[7], [30]
D1631
 
Triamterene
 
C12H11N7
 
5546 
Moderate    Inter Info   
[7], [30]
D1643
 
Trimethaphan
 
C22H25N2OS+
 
23576 
Moderate    Inter Info   
[7], [30]
D1679
 
Valsartan
 
C24H29N5O3
 
60846 
Moderate    Inter Info   
[7], [30]
D1690
 
Verapamil
 
C27H38N2O4
 
2520 
Moderate    Inter Info   
[7], [30]
   Antagonize the effect of cholinergic agents Drug Num:  4
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0052
 
Ambenonium
 
C28H42Cl2N4O2+2
 
2131 
Moderate    Inter Info   
[38], [39], [40]
D0552
 
Edrophonium
 
C10H16NO+
 
3202 
Moderate    Inter Info   
[38], [39], [40]
D1365
 
Pyridostigmine
 
C9H13N2O2+
 
4991 
Moderate    Inter Info   
[38], [39], [40]
D1122
 
Neostigmine
 
C12H19N2O2+
 
4456 
Moderate    Inter Info   
[38], [39], [40]
   Antagonize the effect of corticosteroids Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1063
 
Mifepristone
 
C29H35NO2
 
55245 
Major    Inter Info   
[11], [12]
   Antagonize the effect of vaccine/toxoid Drug Num:  22
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1890
 
Smallpox (Vaccinia) Vaccine, Live
 
NA
 
NA
Major    Inter Info   
[22], [23], [24]
D1838
 
Lyme disease vaccine (recombinant OspA)
 
NA
 
NA
Moderate    Inter Info   
[62]
D0089
 
Anthrax vaccine
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D1744
 
Bacillus calmette-guerin substrain tice live antigen
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72]
D0366
 
Clostridium tetani toxoid antigen (formaldehyde inactivated)
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D0755
 
Hepatitis A Vaccine
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D0756
 
Hepatitis B Vaccine (Recombinant)
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D0767
 
Human papillomavirus type 11 L1 capsid protein antigen
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D0803
 
Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D0804
 
Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D1839
 
Measles virus vaccine live attenuated
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72]
D0999
 
Meningococcal polysaccharide vaccine group C
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D1849
 
Mumps virus strain B level jeryl lynn live antigen
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72]
D1259
 
Pfizer-BioNTech Covid-19 Vaccine
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D1307
 
Poliovirus type 1 antigen (formaldehyde inactivated)
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D1881
 
Rotavirus vaccine
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72]
D1882
 
Rubella virus vaccine
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72]
D1662
 
Typhoid vaccine (inactivated)
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D1914
 
Typhoid vaccine (live)
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72]
D1920
 
Varicella Zoster Vaccine (Recombinant)
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72]
D1692
 
Vibrio cholerae CVD 103-HgR strain live antigen
 
NA
 
NA
Moderate    Inter Info   
[22], [68], [69]
D1922
 
Yellow Fever Vaccine
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72]
   Diminish the response to diagnostic skin test antigens Drug Num:  4
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1755
 
Candida albicans
 
C29H27N2O12P
 
118855431 
Moderate    Inter Info   
[73], [74], [75]
D1765
 
Coccidioides immitis spherule
 
NA
 
NA
Moderate    Inter Info   
[73], [74], [75]
D1912
 
Trichophyton mentagrophytes
 
NA
 
NA
Moderate    Inter Info   
[73], [74], [75]
D1913
 
Tuberculin purified protein derivative
 
NA
 
NA
Moderate    Inter Info   
[73], [74], [75]
   Attenuated pharmacological effects (Unspecific) Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0030
 
Aldesleukin
 
NA
 
NA
Moderate    Inter Info   
[34]
D1812
 
Hyaluronidase
 
C17H24BrNO2
 
91820602 
Minor    Inter Info   
[83], [84], [85]
References
1 Product Information. Cimzia (certolizumab). UCB Pharma Inc, Smyrna, GA.
2 Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
3 FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Drug labels for the Tumor Necrosis Factor-alpha (TNFa) blockers now include warnings about infection with Legionella and Listeria bacteria. ".
4 Sheehan DV, Welch JB, Fishman SM "A case of bupropion-induced seizure." J Nerv Ment Dis 174 (1986): 496-8. [PMID: 3090199]
5 Masco HL, Kiev A, Holloman LC, Batey SR, Johnston JA, Lineberry CG "Safety and efficacy of bupropion and nortriptyline in outpatients with depression." Curr Ther Res Clin Exp 55 (1994): 851-63.
6 Product Information. Wellbutrin XL (buPROPion). GlaxoSmithKline, Philadelphia, PA.
7 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
8 Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
9 Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
10 Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
11 Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
12 Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
13 Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.
14 Cerner Multum, Inc. "Australian Product Information.".
15 Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
16 Bodiford AB, Kessler FO, Fermo JD, Ragucci KR "Elevated international normalized ratio with the consumption of grapefruit and use of warfarin." SAGE Open Med Case Rep 0 (2013): 1-3. [PMID: 27489634]
17 Guo LQ, Yamazoe Y "Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines." Acta Pharmacol Sin 25 (2004): 129-36. [PMID: 14769198]
18 Product Information. Ipravask (desirudin). Aventis Pharmaceuticals, Swiftwater, PA.
19 Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
20 Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
21 Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
22 CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18. [PMID: 20300058]
23 Product Information. Dryvax (smallpox vaccine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
24 CDC. Centers for Disease Control and Prevention "Clinical guidance for smallpox vaccine use in a postevent vaccination program.".
25 Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
26 Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
27 Jori A, Carrara MC "On the mechanism of the hyperglycaemic effect of chlorpromazine." J Pharm Pharmacol 18 (1966): 623-4. [PMID: 4381950]
28 Product Information. Dymelor (acetohexamide) Lilly, Eli and Company, Indianapolis, IN.
29 Product Information. Thorazine (chlorpromazine). SmithKline Beecham, Philadelphia, PA.
30 Multum Information Services, Inc. Expert Review Panel.
31 Morris GC, Egan JG, Jones MK "Hypokalaemic paralysis induced by bolus prednisolone in Graves' disease." Aust N Z J Med 22 (1992): 312. [PMID: 1497563]
32 Thomas TP "The complications of systemic corticosteroid therapy in the elderly." Gerontology 30 (1984): 60-5. [PMID: 6698408]
33 Product Information. Hydeltrasol (prednisolone). Merck &amp Co, Inc, West Point, PA.
34 Product Information. Proleukin (aldesleukin). Chiron Therapeutics, Emeryville, CA.
35 Product Information. Amevive (alefacept). Biogen, Cambridge, MA.
36 Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
37 Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
38 Brunner NG, Namba T, Grob D "Corticosteroids in management of severe, generalized myasthenia gravis." Neurology 22 (1972): 603-10
39 Namba T "Corticotropin therapy in patients with myasthenia gravis." Arch Neurol 26 (1972): 144-50
40 Patten BM, Oliver KL, Engel WK "Adverse interaction between steroid hormones and anticholinesterase drugs." Neurology 24 (1974): 442-9
41 Leavengood DC, Bunker-Soler AL, Nelson HS "The effect of corticosteroids on theophylline metabolism." Ann Allergy 50 (1983): 249-51
42 Fergusson RJ, Scott CM, Rafferty P, Gaddie J "Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction." Thorax 42 (1987): 195-8
43 Buchanan N, Hurwitz S, Butler P "Asthma - a possible interaction between hydrocortisone and theophylline." S Afr Med J 56 (1979): 1147-8
44 Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
45 Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
46 Product Information. Kineret (anakinra). Amgen, Thousand Oaks, CA.
47 Brooks SM, Werk EE, Ackerman SJ, Sullivan I, Thrasher K "Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma." N Engl J Med 286 (1972): 1125-8. [PMID: 4553339]
48 Sehgal VN, Srivastava G "Corticosteroid-unresponsive pemphigus vulgaris following antiepileptic therapy." Int J Dermatol 27 (1988): 258. [PMID: 3391717]
49 Stjernholm MR, Katz FH "Effects of diphenylhydantoin, phenobarbital, and diazepam on the metabolism of methylprednisolone and its sodium succinate." J Clin Endocrinol Metab 41 (1975): 887-93. [PMID: 1184723]
50 Keitner GI, Fruzzetti AE, Miller IW, Norman WH, Brown WA "The effect of anticonvulsants on the dexamethasone suppression test." Can J Psychiatry 34 (1989): 441-3. [PMID: 2766197]
51 Levy RH "Cytochrome P450 isozymes and antiepileptic drug interactions." Epilepsia 36 Suppl 5 (1995): s8-13. [PMID: 8806399]
52 Privitera MR, Greden JF, Gardner RW, Ritchie JC, Calrroll BJ "Interference by carbamazepine with the dexamethasone suppresion test." Biol Psychiatry 17 (1982): 611-20. [PMID: 7093397]
53 Legler UF, Benet LZ "Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives." Clin Pharmacol Ther 39 (1986): 425-9
54 Meffin PJ, Wing LM, Sallustio BC, Brooks PM "Alterations in prednisolone as a result of oral contraceptive use and dose." Br J Clin Pharmacol 17 (1984): 655-64
55 Frey BM, Schaad HJ, Frey FJ "Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone." Eur J Clin Pharmacol 26 (1984): 505-11
56 Product Information. Raptiva (efalizumab). Genentech, South San Francisco, CA.
57 Product Information. AndroGel (testosterone). Unimed Pharmaceuticals, Buffalo Grove, IL.
58 Product Information. Oxandrin (oxandrolone). Bio-Tech, Levittown, PA.
59 Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
60 Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
61 Leach MJ, Page AT. Herbal medicine for insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2015 Dec;24:1-12.
62 Shen AK, Mead PS, Beard CB. The Lyme disease vaccine--a public health perspective. Clin Infect Dis. 2011;52 Suppl 3:s247-s252. [PMID: 21217171]
63 Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC "Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients." J Rheumatol 20 (1993): 263-7. [PMID: 8474062]
64 Roenigk HH, Fowler-Bergfeld W, Curtis GH "Methotrexate for psoriasis in weekly oral doses." Arch Dermatol 99 (1969): 86-93. [PMID: 5761810]
65 Wolff JE, Hauch H, Kuhl J, Egeler RM, Jurgens H "Dexamethasone increases hepatotoxicity of MTX in children with brain tumors." Anticancer Res 18 (1998): 2895-900. [PMID: 9713483]
66 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
67 Product Information. Firdapse (amifampridine). Catalyst Pharmaceuticals, Inc., Coral Gables, FL.
68 Product Information. Imovax Rabies (rabies vaccine). sanofi pasteur, Swiftwater, PA.
69 Department of Health. National Health Service "Immunisation Against Infectious Disease - "The Green Book". Chapter 6: Contraindications and special considerations.".
70 Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998).
71 Product Information. Attenuvax (measles virus vaccine, live, attenuated). Merck &amp Co, Inc, West Point, PA.
72 Product Information. Orimune (poliovirus vaccine, live, oral, trivalent). Lederle Laboratories, Philadelphia, PA.
73 Product Information. Tuberculin PPD (Mantoux) (tuberculin purified protein derivative). Connaught Laboratories Ltd, Toronto, ON.
74 Product Information. Candin (candida albicans extract). Nielsen Biosciences Inc, San Diego, CA.
75 Product Information. Spherulin (coccidioidin skin test). ALK Laboratories Inc, Wallingford, CT.
76 Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
77 Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
78 Product Information. Indium Oxyquinoline In-111 (indium oxyquinoline In-111). GE Healthcare, Princeton, NJ.
79 Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
80 Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
81 Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
82 Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
83 Fuhr U, Maier-Bruggemann A, Blume H, et al. "Grapefruit juice increases oral nimodipine bioavailability." Int J Clin Pharmacol Ther 36 (1998): 126-32. [PMID: 9562227]
84 Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
85 Product Information. Vitrase (hyaluronidase). Bausch and Lomb, Rochester, NY.